Tarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer
Clinical trial NCT07423585 · RECRUITING
Trial details
- NCT number
- NCT07423585
- Sponsor
- Asrar Alahmadi
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-20
- Primary completion
- 2027-12-31
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.